Analyses Mutations in GSN, CST3, TTR, and ITM2B Genes in Chinese Patients With Alzheimer’s Disease
Amyloid protein deposition is a common mechanism of hereditary amyloidosis (HA) and Alzheimer’s disease (AD). Mutations of gelsolin (GSN), cystatin C (CST3), transthyretin (TTR), and integral membrane protein 2B (ITM2B) genes can lead to HA. But the relationship is unclear between these genes and AD. Genes targeted sequencing (GTS), including GSN, CST3, TTR, and ITM2B, was performed in a total of 636 patients with clinical AD and 365 normal controls from China. As a result, according to American College of Medical Genetics and Genomics (ACMG) guidelines, two novel likely pathogenic frame-shift mutations (GSN:c.1036delA:p.K346fs and GSN:c.8_35del:p.P3fs) were detected in five patients with AD, whose initial symptom was memory decline, accompanied with psychological and behavioral abnormalities later. Interestingly, the patient with K346fs mutation, presented cerebral β-amyloid protein deposition, had an early onset (48 years) and experienced rapid progression, while the other four patients with P3fs mutation had a late onset [(Mean ± SD): 69.50 ± 5.20 years] and a long course of illness [(Mean ± SD): 9.24 ± 4.86 years]. Besides, we also discovered 17 variants of uncertain significance (VUS) in these four genes. To our knowledge, we are the first to report AD phenotype with GSN mutations in patients with AD in the Chinese cohort. Although mutations in the GSN gene are rare, it may explain a small portion of clinically diagnosed AD..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Frontiers in Aging Neuroscience - 12(2020) |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yaling Jiang [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Alzheimer’s disease |
|---|
| doi: |
10.3389/fnagi.2020.581524 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ044820976 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ044820976 | ||
| 003 | DE-627 | ||
| 005 | 20230308084439.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fnagi.2020.581524 |2 doi | |
| 035 | |a (DE-627)DOAJ044820976 | ||
| 035 | |a (DE-599)DOAJ2f4080d8e27748f29c78a313e927e41b | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC321-571 | |
| 100 | 0 | |a Yaling Jiang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Analyses Mutations in GSN, CST3, TTR, and ITM2B Genes in Chinese Patients With Alzheimer’s Disease |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Amyloid protein deposition is a common mechanism of hereditary amyloidosis (HA) and Alzheimer’s disease (AD). Mutations of gelsolin (GSN), cystatin C (CST3), transthyretin (TTR), and integral membrane protein 2B (ITM2B) genes can lead to HA. But the relationship is unclear between these genes and AD. Genes targeted sequencing (GTS), including GSN, CST3, TTR, and ITM2B, was performed in a total of 636 patients with clinical AD and 365 normal controls from China. As a result, according to American College of Medical Genetics and Genomics (ACMG) guidelines, two novel likely pathogenic frame-shift mutations (GSN:c.1036delA:p.K346fs and GSN:c.8_35del:p.P3fs) were detected in five patients with AD, whose initial symptom was memory decline, accompanied with psychological and behavioral abnormalities later. Interestingly, the patient with K346fs mutation, presented cerebral β-amyloid protein deposition, had an early onset (48 years) and experienced rapid progression, while the other four patients with P3fs mutation had a late onset [(Mean ± SD): 69.50 ± 5.20 years] and a long course of illness [(Mean ± SD): 9.24 ± 4.86 years]. Besides, we also discovered 17 variants of uncertain significance (VUS) in these four genes. To our knowledge, we are the first to report AD phenotype with GSN mutations in patients with AD in the Chinese cohort. Although mutations in the GSN gene are rare, it may explain a small portion of clinically diagnosed AD. | ||
| 650 | 4 | |a Alzheimer’s disease | |
| 650 | 4 | |a hereditary amyloidosis | |
| 650 | 4 | |a gelsolin | |
| 650 | 4 | |a genetics | |
| 650 | 4 | |a China | |
| 653 | 0 | |a Neurosciences. Biological psychiatry. Neuropsychiatry | |
| 700 | 0 | |a Bin Jiao |e verfasserin |4 aut | |
| 700 | 0 | |a Bin Jiao |e verfasserin |4 aut | |
| 700 | 0 | |a Bin Jiao |e verfasserin |4 aut | |
| 700 | 0 | |a Xinxin Liao |e verfasserin |4 aut | |
| 700 | 0 | |a Xinxin Liao |e verfasserin |4 aut | |
| 700 | 0 | |a Xinxin Liao |e verfasserin |4 aut | |
| 700 | 0 | |a Xuewen Xiao |e verfasserin |4 aut | |
| 700 | 0 | |a Xixi Liu |e verfasserin |4 aut | |
| 700 | 0 | |a Lu Shen |e verfasserin |4 aut | |
| 700 | 0 | |a Lu Shen |e verfasserin |4 aut | |
| 700 | 0 | |a Lu Shen |e verfasserin |4 aut | |
| 700 | 0 | |a Lu Shen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Frontiers in Aging Neuroscience |d Frontiers Media S.A., 2010 |g 12(2020) |w (DE-627)DOAJ000118893 |x 16634365 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2020 |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fnagi.2020.581524 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/2f4080d8e27748f29c78a313e927e41b |z kostenfrei |
| 856 | 4 | 0 | |u https://www.frontiersin.org/article/10.3389/fnagi.2020.581524/full |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1663-4365 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2020 | ||